Titre:home | gelexir.healthcare® ltd
La description :gelexir healthcare ltd, manchester, home uk, is introducing a novel, non-surgical procedure for the treatment of chronic lower back pain......
Classement Alexa Global: # 19,510,894
Server:Apache/2.4.18 (Ubunt...
L'adresse IP principale: 37.187.190.164,Votre serveur France,Roubaix ISP:OVH SAS TLD:uk Code postal:fr
Ce rapport est mis à jour en 11-Jun-2018
Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations. Notre service GeoIP a trouvé l'hôte gelexir-healthcare.co.uk.Actuellement, hébergé dans France et son fournisseur de services est OVH SAS .
Latitude: | 50.69421005249 |
Longitude: | 3.1745600700378 |
Pays: | France (fr) |
Ville: | Roubaix |
Région: | Nord-Pas-de-Calais |
ISP: | OVH SAS |
domaine | Titre |
---|
Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé Apache/2.4.18 (Ubuntu) contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.
X-XSS-Protection: | 1; mode=block |
Content-Language: | uk |
X-Content-Type-Options: | nosniff |
Content-Encoding: | gzip |
Transfer-Encoding: | chunked |
Strict-Transport-Security: | max-age=15768000; includeSubDomains; preload |
Vary: | Accept-Encoding |
Keep-Alive: | timeout=5, max=100 |
Server: | Apache/2.4.18 (Ubuntu) |
Connection: | Keep-Alive |
Link: | |
Date: | Mon, 11 Jun 2018 09:51:19 GMT |
Content-Type: | text/html; charset=UTF-8 |
soa: | dns.gsi-network.com. dns.gsi-network.com. 2018060802 7200 540 2419200 3600 |
txt: | "v=spf1 mx a ~all" |
ns: | sdns2.ovh.net. dns.gsi-network.com. |
ipv4: | IP:37.187.190.164 ASN:16276 OWNER:OVH, FR Country:FR |
mx: | MX preference = 10, mail exchanger = mail.gelexir-healthcare.co.uk. |
home company presentation gelexir healthcare ltd, manchester, uk, is introducing a novel, non-surgical procedure for the treatment of chronic lower back pain (clbp) caused by degenerative disc disease (ddd). gelexir healthcare, originating from the university of manchester, develops a novel approach which addresses ddd at an early stage before the onset of irreversible disc degeneration of both the nucleus pulposus and annulus fibrosis material. news: december 2017 gelexir expands with the opening of a french subsidiary, incubated at ecole polytechnique, the #1 french engineering school. november 2017 gelexir has successfully been audited by lloyd register quality assurance and obtained the iso 13485 certification of its r&d and manufacturing organisation. september 2017 gelexir is proud to announce that innovate uk, the uk’s innovation agency, granted funding to help the company develop its second product , a gel based solution to address painful osteoarthritic finger and other small joints for the patients to minimise the pain and improve the range of motion. the program starts in september 2017. january 2016 gelexir is proud to announce the uspto granted its microgel particle patent (us9242028 b2) in january 2016. this decision is important as it strengthens the patent portfolio owned by the company. the microgel particle patent has already been granted in europe, japan, korea, canada, australia. the microgel compositions patent is progressing well through the pct process wo 2011/101684. january 2015 gelexir highlighted in the special issue from medtech strategist: the medtech strategist features detailed profiles of 20 emerging medical technology companies identified by our seasoned editorial team as poised to impact the device space . include gelexir healthcare : bridging the gap in degenerative disc disease – click here for more info technology home chronic low back gelexir concept gelexir material gelexir procedure publications contact us about about gelexir about us contact us disclaimer copyright © 2016 - gelexir-healthcare.co.uk
https://www.gelexir-healthcare.co.uk/about-us/
https://www.gelexir-healthcare.co.uk/publications/
https://www.gelexir-healthcare.co.uk/contact-us/
https://www.gelexir-healthcare.co.uk/gelexir-procedure/
https://www.gelexir-healthcare.co.uk/
https://www.gelexir-healthcare.co.uk/gelexir-material/
https://www.gelexir-healthcare.co.uk/disclaimer/
https://www.gelexir-healthcare.co.uk/about-gelexir/
https://www.gelexir-healthcare.co.uk/gelexir-concept/
https://www.gelexir-healthcare.co.uk/chronic-low-back/
Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;
Error for "gelexir-healthcare.co.uk".
the WHOIS query quota for 2600:3c03:0000:0000:f03c:91ff:feae:779d has been exceeded
and will be replenished in 447 seconds
WHOIS lookup made at 06:50:00 12-Aug-2017
--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.
REFERRER http://www.nominet.org.uk
REGISTRAR Nominet UK
SERVERS
SERVER co.uk.whois-servers.net
ARGS gelexir-healthcare.co.uk
PORT 43
TYPE domain
RegrInfo
DISCLAIMER
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.
REGISTERED no
DOMAIN
NAME gelexir-healthcare.co.uk
NSERVER
DNS.GSI-NETWORK.COM 37.59.32.166
SDNS2.OVH.NET 213.251.188.141
La liste suivante vous montre les fautes d'orthographe possibles des internautes pour le site Web recherché.